The benefit of chemotherapy in elderly patients with small cell lung cancer

    loading  Checking for direct PDF access through Ovid

Abstract

Elderly patients with small cell lung cancer derive a statistically significant benefit from the administration of combination chemotherapy. Numerous clinical trials have demonstrated high response rates and impressive median survivals with carboplatin and etoposide, cisplatin and etoposide, and other regimens. All elderly patients with small cell lung cancer should be evaluated by a medical oncologist to determine whether they are candidates for chemotherapy.

Related Topics

    loading  Loading Related Articles